Author:
Laforce Brecht,Carlier Charlotte,Vekemans Bart,Villanova Julie,Tucoulou Rémi,Ceelen Wim,Vincze Laszlo
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C. & Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127, 2893–2917 (2010).
2. Bast, R. C., Hennessy, B. & Mills, G. B. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9, 415–428 (2009).
3. Zivanovic, O. et al. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. International journal of cancer Journal international du cancer 136, 699–708 (2015).
4. Bijelic, L., Sugarbaker, P. H. & Stuart, O. A. Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients. Gastroenterology Research and Practice 2012, 5 (2012).
5. van der Vange, N. et al. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 26, 663–668 (2000).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献